Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atypical antipsychotics for bipolar disorder.

Lakshmi N Yatham1

  • 1Mood Disorders Clinical Research Unit, University of British Columbia, Room 2C7-2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada. yatham@interchange.ubc.ca

The Psychiatric Clinics of North America
|April 14, 2005
PubMed
Summary

Atypical antipsychotics effectively treat acute mania in bipolar disorder, offering alternatives to lithium and divalproex. Limited data exist for bipolar depression and long-term maintenance, requiring further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder.

Journal of psychiatric research·2026
Same author

Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older-Age Bipolar Disorder ISBD Task Forces.

Bipolar disorders·2026
Same author

Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus Report.

Bipolar disorders·2026
Same author

A Chatbot for the Management of Bipolar Disorder: Using Retrieval-Augmented Generation With an Open-Weight Large Language Model to Answer Clinical Questions Based on the CANMAT and ISBD 2018 Guidelines for Bipolar Disorder: Un dialogueur pour la prise en charge du trouble bipolaire : utiliser la génération augmentée par récupération avec un grand modèle de langage (GML) à poids ouverts pour répondre aux questions cliniques fondées sur les lignes directrices de 2018 de CANMAT et de l'ISBD relatives au trouble bipolaire.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

Transcranial Magnetic Stimulation for Bipolar Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Stimulation magnétique transcrânienne dans les cas de dépression bipolaire : une revue systématique et une méta-analyse d'essais contrôlés à répartition aléatoire.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

Brain Morphology Mediators of the Association of Childhood Trauma With Bipolar Disorder: An International ENIGMA Bipolar Disorder Working Group Study.

JAMA psychiatry·2026

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Atypical antipsychotics are increasingly used for bipolar disorder.
  • Their efficacy in acute mania is established, but data for depression and maintenance are limited.

Purpose of the Study:

  • To review the efficacy of atypical antipsychotics in managing acute mania, bipolar depression, and for maintenance treatment in bipolar disorder.
  • To compare their effectiveness against traditional mood stabilizers.

Main Methods:

  • Systematic review of existing clinical trial data on atypical antipsychotics (olanzapine, risperidone, quetiapine, aripiprazole, ziprasidone).
  • Analysis of efficacy in acute mania, bipolar depression, and long-term prophylaxis.

Main Results:

  • Atypical antipsychotics show comparable efficacy in acute mania, serving as alternatives to lithium and divalproex.

Related Experiment Videos

  • Olanzapine demonstrates modest antidepressant properties; quetiapine shows promising antidepressant effects needing replication.
  • Aripiprazole shows potential for mania prevention, requiring longer-term studies.

    • Conclusions:

    • Atypical antipsychotics are effective and safe additions for acute mania treatment in bipolar disorder.
    • Further research is essential to define their roles in acute bipolar depression and long-term maintenance therapy.